Ixekizumab

1 Drug classified under this active ingredient

Interleukin Inhibitor. Ixekizumab 80 mg/ml.
PRE FILL. PEN: 1.
160 mg by SC inject. (Two 80 mg inject.) at Week 0, follow. by 80 mg (1 injec.) at Weeks 2, 4, 6, 8, 10, and 12, then maint. dosing of 80 mg (1 inj.) every 4 wks. Consider. should be given to discount. tmt. in pts. who have shown no response after 16 -20 wks. of tmt. Some pts. with init. partial response may subseq. improve with contin. tmt. beyond 20 wks.
Tmy. of moder.-sev. plaque psoriasis in
adult. who are candidat. for system. ther.
C/I: Serious hypersens. Clinical. important active infec.